CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $23,000 | -61.0% | 4,708 | -9.9% | 0.00% | – |
Q4 2021 | $59,000 | +5.4% | 5,225 | +36.2% | 0.00% | – |
Q3 2021 | $56,000 | +1766.7% | 3,835 | +1398.0% | 0.00% | – |
Q2 2021 | $3,000 | -40.0% | 256 | -40.6% | 0.00% | – |
Q1 2021 | $5,000 | 0.0% | 431 | 0.0% | 0.00% | – |
Q4 2020 | $5,000 | -99.7% | 431 | -99.6% | 0.00% | -100.0% |
Q3 2020 | $1,460,000 | -82.2% | 97,014 | -71.0% | 0.00% | -85.0% |
Q2 2020 | $8,197,000 | +564.3% | 334,432 | +284.5% | 0.02% | +400.0% |
Q1 2020 | $1,234,000 | +609.2% | 86,986 | +693.5% | 0.00% | – |
Q4 2019 | $174,000 | – | 10,962 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |